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Abbreviations:
BBB-blood-brain barrier
Do/a-octanol/aqueous partitioning coefficient
F-regional cerebrovascular flow
J-influx
Kd-diffusion constant
Kin-influx transfer coefficient
Km-Michaelis-Menten constant
MMT-methylcyclopentadienyl manganese tricarbonyl
Mn-manganese
MW-molecular weight
Pdiffusion-estimated permeability due to diffusion
PS-permeability-surface area product
Q-uptake space
Tf-transferrin
Vmax-maximum velocity of carrier-mediated transport
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Abstract: Manganese (Mn) is an essential element and a neurotoxicant. Regulation of
Mn movement across the blood-brain barrier (BBB) contributes to whether the brain Mn
concentration is functional or toxic. In plasma, Mn associates with water, small
molecular weight ligands and proteins. Mn speciation may influence the kinetics of its
movement through the BBB. In the present work, the brain influx rates of 54Mn2+, 54Mn
citrate and 54Mn transferrin (54Mn Tf) were determined using the in situ brain perfusion
technique. The influx rates were compared to their predicted diffusion rates, which were
determined from their octanol/aqueous partitioning coefficients and molecular weights.
The in situ brain perfusion fluid contained 54Mn2+, 54Mn citrate or 54Mn Tf and a vascular
volume/extracellular space marker, 14C-sucrose, which did not appreciably cross the
BBB during these short experiments (15-180 seconds). The influx transfer coefficient
(Kin) was determined from four perfusion durations for each Mn species in nine brain
regions and the lateral ventricular choroid plexus. The brain Kin was 5-13, 3-51, and 213 x 10-5 ml/sec/g for 54Mn2+, 54Mn citrate, and 54Mn Tf, respectively. Brain Kin values
for any one of the three Mn species generally did not significantly differ among the nine
brain regions and the choroid plexus. However, the brain Kin for Mn citrate was greater
than Mn2+ and Mn Tf Kin values in a number of brain regions. When compared to
calculated diffusion rates, brain Kin values suggest carrier-mediated brain influx of
54

Mn2+, 54Mn citrate and 54Mn Tf.

55

Mn citrate inhibited 54Mn citrate uptake, and 55Mn2+

inhibited 54Mn2+ uptake, supporting the conclusion of carrier-mediated brain Mn influx.
The greater Kin values for Mn-citrate than Mn2+ and its presence as a major non-proteinbound Mn species in blood plasma suggest Mn citrate may be a major Mn species
entering the brain.
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INTRODUCTION
Manganese (Mn) is an essential trace element for normal brain development and
function (Smith, 1990; Keen et al., 2000; Sigel and Sigel, 2000). It is a cofactor for a
variety of enzymes in the brain, for example, the glial-specific enzyme glutamine
synthetase, which accounts for 80% of the brain concentration of Mn (Wedler and
Denman, 1984). Excess brain Mn produces a parkinsonian syndrome (manganism)
(Hudnell, 1999; Iregren, 1999) that is associated with neurotransmitter damage,
particularly to dopaminergic systems (Verity, 1999). Symptoms of manganism include
reduced coordination, hallucinations, and hyperirritability (Schuler et al., 1957; Mena et
al., 1967). Symptoms progress and the chances of recovery diminish with prolonged
exposure. Since both insufficient and excessive brain Mn concentrations lead to altered
CNS function, it is anticipated that homeostatic regulation of Mn influx and efflux at brain
barriers is essential to maintain a healthy brain Mn concentration. Neurotoxicity has
been reported in miners exposed to manganese dioxide by inhalation (Couper, 1837),
workers in dry-cell battery factories (Keen and Lönnerdal, 1995) and people drinking well
water that was contaminated by buried dry cell batteries (Hudnell, 1999). There is
concern about airborne Mn exposure from methylcyclopentadienyl manganese tricarbonyl
(MMT) (Hudnell, 1999), which was recently approved as a fuel additive in the U.S., and
fungicides such as ethylenebis(dithiocarbamato)manganese (Maneb).

Central to homeostatic regulation of brain Mn levels is the exchange of Mn between
blood plasma and brain tissue. Mn can enter the brain from blood plasma by crossing
the capillary endothelial cells of the blood-brain barrier (BBB) or the choroid plexuses
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into CSF and then into the brain (Bradbury, 1997). Brain Mn entry may be mediated by
diffusion or carrier-mediated processes. At physiologic Mn concentrations of ~20 nM in
serum (Keen et al., 2000), brain influx was reported to be non-saturable and primarily
through the capillary endothelium of the BBB, while Mn influx at high plasma
concentrations was saturable and primarily via the CSF (Murphy et al., 1991; Rabin et
al., 1993). Mn brain influx can also occur through a transferrin-dependent mechanism
(Aschner and Gannon, 1994). However, transferrin (Tf) was found not to be necessary
to achieve or maintain normal brain Mn levels in mice with very low plasma transferrin
levels (Malecki et al., 1999), suggesting that Tf-independent mechanisms can maintain
brain Mn homeostasis.

The chemical speciation of Mn affects its diffusion and transport into the brain.
Thermodynamic modeling of Mn2+ in serum suggests it exists in several forms, including
an albumin-bound species (84%), as a hydrated ion (6.4%) and in 1:1 complexes with
HCO3- (5.8%), citrate3- (2.0%) and other small molecular weight ligands (1.8%) (Harris
and Chen, 1994). Similar modeling of Mn3+ in serum predicts that it is almost 100%
bound to transferrin (Aisen et al., 1969); Harris and Chen 1994). It is unclear whether
there is a predominant Mn species crossing the BBB, and if so, the identity of that
species.

The objective of this study was to evaluate the brain entry rate(s) of Mn to test the
hypothesis that 54Mn2+, 54Mn citrate and 54Mn Tf enter the brain via one or more carriermediated processes. We determined the brain influx rates (Kin) of these three Mn
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species, which represent the unbound, small ligand-complexed and protein-bound
fractions of Mn in plasma. We estimated their diffusion rates across the BBB, based on
lipophilicity and molecular weight, and compared the Kin values to their predicted
diffusion rates. Significantly greater brain influx rates than the calculated diffusion rates
were taken as evidence of the presence of carrier-mediated processes. The results of
studies in this report support the conclusion that 54Mn2+, 54Mn citrate and 54Mn Tf brain
influxes are carrier-mediated.

MATERIALS AND METHODS
54

MnCl2 (specific activity 28 to 7600 nCi/ng) in 0.1-0.5 M HCl was purchased from

Perkin-Elmer/NEN (Boston, MA) and Isotope Products Laboratories (Burbank, CA).
[14C]-sucrose was purchased dry from NEN (3.6 nCi/nmol) and in 2% ethanol from
Moravek (Brea, CA; 495 nCi/nmol). All other chemicals were purchased from Sigma
(St. Louis, MO) unless otherwise noted. Sprague-Dawley rats (250-350 g) were
purchased from Harlan (Indianapolis, IN, USA). All animal research was conducted
under the guidelines of the Guide for the Care and Use of Laboratory Animals and with
the approval of the University of Kentucky Institutional Animal Care and Use Committee.

Preparation of 54Mn citrate and 54Mn transferrin (54Mn Tf)
54

Mn citrate was prepared by incubating 54MnCl2 with a 10 % molar excess of Na3citrate

for one hour at 37°C (Pavlinova and Shnarevich, 1960; Schnarevich, 1963). Near
infrared comparison of citrate and the putative Mn citrate suggested the formation of the
1:1 complex. To form 54Mn Tf, 54MnCl2 and apo-transferrin in a ratio of 3 54Mn: 4 metal
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binding sites were incubated in 15 mM HCO3- for one hour at 37°C. Evidence we
obtained for formation of this complex included 1) a reduction of the ability of Mn to pass
through a 10 kDa molecular weight cut-off filter, and 2) increased UV absorbance at 300
nm following incubation. Equilibrium dialysis studies of 55Mn and transferrin indicated
that 19% of the total 55Mn in the perfusate was not associated with transferrin.

Study I: Estimation of diffusion rates
The distribution (partitioning) (Do/a) of non-radioisotopic ( 55Mn) Mn+2,Mn citrate and Mn
Tf between octanol and an aqueous phase was determined as previously conducted
(Yokel and Kostenbauder, 1987). The aqueous phase was modified to exclude HCO3in the Mn2+ and Mn citrate systems, because it is a potential ligand for Mn; however,
HCO3- is necessary for Mn Tf formation. Octanol/aqueous systems were agitated
overnight at 37 °C to establish equilibrium. Mn concentrations in the octanol and
aqueous phases were determined by electrothermal atomic absorption spectrometry.
Permeability through the BBB by diffusion (Pdiffusion, in cm/s) of each Mn species was
estimated based on the relationship between molecular weight (MW) and the Do/a, as
described (Levin, 1980):

log Pdiffusion = -4.605 +.4115*log (Do/a÷MW1/2)

The permeability × surface area product (PdiffusionS, in ml/s/g brain) was then calculated
by multiplying diffusion permeability by rat brain capillary surface area (240 cm2/g;
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(Crone, 1963), as described (Smith, 1989). This predicted diffusion rate has the same
units as Kin and Kout, which are measures of influx and efflux at the BBB.

Study II: Determination of Kin
This study was conducted to determine the transfer rate of 54Mn2+, 54Mn citrate and
54

Mn Tf from the vascular space to the brain. Manganese uptake was measured as a

function of time. Uptake was determined at four to five perfusion durations for each
54

Mn species. The perfusion durations were selected to yield uptakes that were within

the linear portion of the uptake curve, where efflux is insignificant in relation to uptake.
For 54Mn2+, the durations were 30, 60, 90 and 180 seconds, with n=11, 10, 10 and 10
animals, respectively.
54

54

Mn Tf data used the same durations, with n=7 at all times.

Mn citrate uptake was determined at 15, 30, 45, 60 and 90 seconds (n= 7, 11, 7, 11,

4). Data were graphed as uptake versus time to determine Kin, as described in
Statistical Analysis, below.

Preparation of perfusate
Perfusate contained 2-5 µCi/ml 54Mn (5-12 nM 54Mn) as Mn2+ or Mn citrate in a solution
of Na+ (153 mM), K+ (4.2 mM), Ca2+ (1.5 mM), Mg2+ (0.9 mM), Cl- (162 mM) and
glucose (9 mM). The perfusate for 54Mn Tf contained 15 mM HCO3- and 147 mM Clwith the remaining ion concentrations unchanged. A marker for vascular and
extracellular space, 14C-sucrose (1 µCi/ml), was added. It has been shown not to cross
the intact BBB in the time course of these experiments (Takasato et al., 1984).
Following at least one hour incubation at 37 °C, the solution was bubbled two minutes

9

with 95:5 air/CO2 and adjusted to a pH of 7.4 + 0.2. Animals received the perfusate
between 0.25-4 hours after its preparation, during which time the pH was stable and the
temperature maintained at 37 °C.

In situ brain perfusion technique
The brain perfusion technique (Takasato et al., 1984) was used, as modified in the
laboratories of Drs. Quentin Smith and David Allen (Smith, 1996; Allen and Smith,
2001). Briefly, the rat was placed under ketamine/xylazine anesthesia (75:5 mg/kg),
and one carotid artery exposed. Following ligation of the external carotid, common
carotid and the first branch of the internal carotid arteries, the internal carotid was
cannulated with PE50 tubing containing 100 U heparin /ml in 0.9% NaCl. Under
anesthesia, the animal’s heart was cut and perfusion through the PE50 tubing initiated
within 3 seconds. The animal was decapitated to end the perfusion. Perfusate was
maintained at 37 °C until loading into the syringe 30-90 seconds before the experiment.
With the original method, the pterygopalatine artery was also ligated and the perfusion
fluid included cells or plasma proteins. The heart-cut modification (Smith, 1996)
requires increased fluid flow rate (up to 20 ml/min) to account for the lowered viscosity
of physiologic perfusates and loss through the non-ligated pteryogopalatine artery.

The brain was harvested and cleaned of meninges and surface vessels. Tissue
samples ipsilateral to perfusion were collected from the nine brain regions listed in
Table 2. One lateral ventricle choroid plexus was also collected. Contralateral brain
tissues from five regions (frontal, parietal and occipital cortices; cerebellum and
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caudate) were also collected. Tissue samples and two 20-50 µl aliquots of perfusate
were weighed in tared vials and analyzed for radioactivity as noted below.

Study III: Flow Rate Dependency of the Mn Influx Rate
This study examined the effect of perfusion flow rate on influx rate. Flow-rate
dependent uptake is a property of some carrier-mediated uptake systems, but is not a
property of diffusion. Animals were prepared for in situ brain perfusion as described
above. They were paired to receive the 54Mn2+/[14C]-sucrose perfusate described above
at flow rates of 10 or 20 ml/min. Four pairs of animals were completed at 30, 60, 90 and
180 seconds.

Study IV: Isolation of the capillary fraction
This study differentiated 54Mn reaching brain extracellular fluid from 54Mn adsorbed onto
or localized within endothelial cells. The capillary depletion method (Triguero et al.,
1990) separates brain tissue from capillary tissue. In this study, the brains were
perfused, using the in situ brain perfusion technique, prior to separation into capillary
and brain fractions.

Animals were prepared as above and perfused at 10 ml/min through the right carotid
artery. Perfusion durations of 90, 45 and 90 seconds for 54Mn2+, 54Mn citrate and 54Mn
Tf, respectively, were chosen to maximize uptake while remaining within the linear
portion of the uptake curves for all brain regions. The forebrain was isolated and the
right lateral ventricle choroid plexus was removed. The tissue was homogenized in 3.5
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ml ice-cold buffer with 8-10 strokes in a 15-ml Tenbroeck tissue grinder (Wheaton
Scientific, Milville NJ). The buffer contained 141 mM NaCl, 4 mM KCl, 2.8 mM CaCl2, 1
mM NaH2PO4, 1 mM MgSO4, 10 mM glucose and 10 mM HEPES at pH 7.4. Dextran
(70,000 g/mol) was added to a final concentration of 18% wt/vol and the solution
homogenized with five additional strokes. After centrifugation at 5400 × g for 15
minutes at 4 °C, the supernatant (capillary-poor fraction) and pellet (capillary-enriched
fraction) were separated and counted for radioactivity. This separation technique
produced a three-fold enrichment of alkaline phosphatase (EC 3.1.3.1) activity, a
capillary-specific enzyme, in the capillary-enriched fraction (25 U/ mg protein) using the
enzyme activity kit (104-L) from Sigma (St. Louis, MO). Microscopic examination
confirmed the presence of capillary fragments in the capillary-enriched fraction, which
were not observed in the capillary-poor fraction.

Study V: Effect of 55Mn2+ on 54Mn2+ uptake and 55Mn citrate on 54Mn citrate
uptakeThe objective of this study was to differentiate carrier-mediated from diffusional
uptake processes. The diffusion rate depends on membrane and substrate properties,
and is concentration-independent. Transporters, like enzymes, have limited capacities
and can be saturated. Nonradioactive substrate competes with radioactive substrate for
transporter binding sites and ultimately for transport across the membrane. If uptake is
carrier-mediated, 55Mn2+ should inhibit the uptake of 54Mn2+ and 55Mn citrate should
inhibit 54Mn citrate uptake. This inhibition should be concentration-dependent.
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Using the in situ brain perfusion technique described above, the influx of 7 nM 54Mn2+
was measured in the presence of 0, 1 X 102, 103, 104, 105, 106 and 107 nM 55Mn2+. The
influx of 7 nM 54Mn citrate was measured in the presence of 0, 1 X 102, 103, 104, 105
and 107 nM 55Mn citrate. Isolated brains were cleaned and dissected into nine brain
regions and the choroid plexus, and tissue samples were prepared as above for
radioactivity determination.

Analysis of radioactivity in studies II-V
Gamma radioactivity of 54Mn was measured from 750-1090 keV with a Packard Cobra II
gamma counter with 17.8% efficiency or a Packard MinAxi gamma counter with 16.8%
efficiency. Brain tissue weighing up to 600 mg did not have any quenching effect on 50
µCi 54Mn activity. After gamma counting the tissues were digested by overnight
incubation in 10% (vol/vol) piperidine at 55 °C. Following digestion, samples were
transferred to borosilicate glass vials. BioSafe II scintillant (Research Products
International, Mount Prospect, IL) was added to the sample (≥5:1 vol/vol ratio). Beta
radioactivity of 14C was measured from 6-156 keV with a Packard Tri-Carb 2200A liquid
scintillation counter.

54

Mn produced a signal in the beta window from 0-12 keV, which

overlapped the normal 14C signal (0-156 keV). The counting window of 6-156 keV was
selected to minimize both the contribution of 54Mn to the beta counts (a gain of 4.7% of
the 54Mn dpm) and the reduction of 14C activity due to the narrower beta counting
window (a loss of 13.2% of the total 14C cpm). Digested brain from 0 to 600 mg was
found to quench linearly the 14C signal within this window, with 0.0524% cpm loss/mg
brain. Efficiency of the Packard TriCarb 2200A for the 0-156 keV 14C window was
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96.1% for the unquenched standards. Taken together, these produced a correction
equation as follows:

14

C dpm =

(14C cpm – 0.047* 54Mn dpm)*(1+0.524*g brain)
(1-0.132)*(0.961)

This equation was used for all tissue samples. Perfusate sample results were analyzed
using a similar equation without the correction for brain quenching.

Data and Statistical Analysis
Calculation of Kin
The influx transfer coefficient (Kin) is a measure of the rate of influx of a substance in a
given time into a given amount (space) of brain. It is the quotient of uptake space and
time, and it reflects the volume of perfusate cleared of substrate which is transferred
into one gram of brain over a given time period. The distribution volume, or uptake
space (Q), is the amount of brain tissue into which the substrate distributes during a
given perfusion duration. Uptake spaces (Q) in ml/g brain of 54Mn and 14C were
calculated as:

Q=

the amount of radioactivity per weight tissue (dpm/g)
the amount of radioactivity per volume of perfusate (dpm/ml)

The 54Mn uptake space results were corrected for the sample's vascular/ extracellular
space by subtracting the 14C-sucrose uptake space, i.e., Corrected QMn, = QMn total Qsucrose. Thus,

14

Mnbrain dpm/g
54
Mnperf. dpm/ml
54

Corrected QMn =

C-sucrosebrain dpm/g
C-sucroseperf. dpm/ml

14

-

14

The second fraction (Qsucrose) averaged 0.011 ml/g brain at 90 s. The corrected uptake
spaces were plotted against perfusion time. Extreme values were tested by Dixon’s
criterion to determine whether they were outliers. To test for linearity, ANOVAs of
uptake space versus time data were generated for each tissue and each Mn species.
The F test determined linearity. If uptake was not linear throughout the four perfusion
durations, the lower three perfusion durations (30, 60 and 90 s for Mn2+ and Mn Tf; 15,
30 and 45 s for Mn citrate) were tested for linearity. The linear least-squares regression
of the data points was plotted using Microsoft Excel. The slope of the regression line is
an estimate of the influx transfer coefficient (Kin). For 54Mn Tf data, the 54Mn activity in
dpm was corrected for the contribution of 54Mn2+, which accounted for 19% of the 54Mn
in the perfusate, as described above in Preparation of 54Mn citrate and 54Mn transferrin
(Mn Tf). For perfusate samples, the correction simply decreased total dpm by 19%. In
tissue samples, this correction is the product of the tissue Kin for 54Mn2+, the perfusion
time and the concentration of 54Mn2+ as below:

54

Mn Tf dpm/g = total 54Mn dpm/g – (total 54Mn dpm/ml * 0.19)*(time, in s)*(Kin, in ml/s/g)

For study V, Kin values were converted to PS (cerebrovascular permeability-surface
area product) values according to the equation (Smith, 1989):

PS = -vF*ln (1-Kin/vF)
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where F is the regional flow and v is the fractional distribution of tracer in blood (for
perfusate, v = 1). The units of PS are ml/s/g. Influx (J) was calculated as the product of
PS and Mn concentration and had the units of nmoles/s/g. The graphs of mean J
versus concentration (C) were plotted and fit to the following Michaelis-Menten
equations:

J0 = Kd*C
J1 = Vmax C/[Km + C] + Kd*C
J2 = Vmax2*C/[Km2 + C] + Vmax*C/[Km + C] + Kd*C

where J0, J1 and J2 each represent one fit of the same J data set, Kd is the diffusional
constant, C is concentration of total Mn (in nM), Vmax is the maximum velocity of the
putative transporter(s), and Km is the Michaelis-Menten constant of saturable uptake.
Kd*C represents the non-saturable component(s) of uptake. The F-test was used to
determine the best-fitting model for each tissue and each Mn species. The Km and Vmax
values were determined using SAAM II and/or GraphPad Prizm computer software
programs.

Differences between tissue Kin values and predicted diffusion rates were compared by ttests, using Bonferroni’s correction for multiple testing. In single time point experiments
(studies IV and V), the Kin values were determined by directly dividing each uptake
space (ml/g) by its perfusion duration (seconds). Comparisons were made by t-test with
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Bonferroni’s correction factor (study IV) or with Dunnett’s test (study V). For all studies,
a difference of p < 0.05 was accepted as statistically significant.

RESULTS
Study I: Estimates of brain capillary diffusion rates
The predicted diffusion rates of 54Mn, 54Mn citrate and 54Mn Tf are shown in Table 1. All
values were estimated to be less than 3 X 10 –5 ml/s/g brain. As a comparison, the
diffusion rates of sucrose and dextran were also estimated from their published octanolaqueous partitioning coefficients (Levin, 1980; Huang, 1990) and formula weights.

Study II: Estimates of Kin
Influx transfer coefficients (Kin) were determined graphically for each tissue and each
Mn species. Figure 1 shows uptake values for the parietal cortex, a representative
brain region, over the time course of the experiment. For comparison, the uptake rates
predicted by diffusion are plotted on each graph. For the nine brain regions studied, the
Kin values ranged from 5-13, 3-51, and 2-13 × 10-5 ml/s/g for 54Mn2+, 54Mn citrate and
54

Mn Tf, respectively.

Influx coefficients for each 54Mn species were compared to their corresponding
estimated diffusion rates. Significant differences between Kin values and the predicted
diffusion rates are noted in Table 2 for each tissue. These Kin values were derived from
the individual data rather than the mean uptake values shown in Figure 1. With each
54

Mn species, there was at least one brain region for which the 54Mn influx rate
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exceeded that predicted for diffusion. Influx into the choroid plexus was generally at
least ten-fold greater than influx into the brain regions for each 54Mn species.

Within a given brain region, the influx rates were compared across Mn species.

54

Mn

citrate influx rates were generally higher than 54Mn2+ and 54Mn Tf and were significantly
different in a number of brain regions, as shown in Table 2.

Study III: Flow rate dependency
Comparison of Kin at 10 and 20 ml/min did not show a significant effect of flow rate on
brain Mn uptake in any of the nine brain regions or the choroid plexus (data not shown).
Furthermore, there were no differences in the space occupied by 14C-sucrose (Table 3),
which represents the vascular volume.

Study IV: Isolation of capillaries
Separation of the capillaries from the brain parenchyma revealed that some of each Mn
species completely crossed the endothelial cell layer and entered the brain extracellular
fluid and/or the brain cells. A small amount of the radioactivity in brain tissue was
associated with the capillary endothelial cells. Most of the brain-associated radioactivity
for 54Mn2+, 54Mn citrate and 54Mn Tf (92 ± 2, 89 ± 2, and 75 ± 10 %; mean % ± SD,
respectively) passed through the endothelial cells into brain cells or brain extracellular
fluid. The results in Table 2 have been adjusted to account for the fraction of 54Mn
associated with the endothelial cells.
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Study V: Effect of 55Mn2+ on 54Mn2+ uptake and 55Mn citrate on 54Mn citrate uptake
In the presence of increasing amounts of 55Mn2+, the influx rate of 7 nM 54Mn2+ was
reduced in the choroid plexus, the frontal and parietal cortex, the hippocampus, the
caudate and the pons/medulla regions. This was not a concentration-dependent effect
over the 106-fold concentration range studied (Fig. 2A).

55

Mn citrate significantly

inhibited uptake of 7 nM 54Mn citrate in the caudate and parietal cortex (Fig. 2B) and the
choroid plexus (data not shown) at the highest concentration studied (107 nM).

The concentration and velocity of brain uptake data were fit to models of enzyme
kinetics involving zero, one and two Michaelis-Menten terms. Seven of eight 54Mn
citrate-treated and two of eight 54Mn2+-treated regions (caudate and
thalamus/hypothalamus) were best fit by J1 described as:

J1 = Vmax* C/[Km + C] + Kd*C

The remaining regions were best fit by J0, the diffusion-only model of brain Mn uptake.
Nonlinear regression analysis by SAAM II and Graph Pad Prizm of the Mn influx vs.
concentration graphs generated very high values for Km and some negative Vmax values.
Statistically this results from the apparent lack of concentration-dependent inhibition
over the concentration range tested. Due to this, Km and Vmax values for most tissues
are not reported. Only in the caudate region was there evidence for uptake of both
Mn2+ and Mn citrate via a single carrier model. The Vmax values (mean ± SEM) for Mn
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citrate and Mn2+ were significantly different (0.26 ± 0.01 vs. 0.31 ± 0.01 nmol/s/g brain,
respectively).

DISCUSSION
This study provides evidence for carrier-mediated influx of Mn2+, Mn citrate and Mn Tf
through the cells comprising the BBB. This influx is independent of flow rate. Mn Tf
influx is likely due to transferrin receptor-mediated endocytosis. Furthermore, the results
suggest different affinities for one carrier or different carriers for Mn2+ and Mn citrate, as
described below. This suggests that Mn citrate may be a significant chemical species of
Mn transferred across the BBB.

This is the first report to examine 54Mn brain uptake with control of its chemistry.
Several studies (Aschner and Aschner, 1990; Murphy et al., 1991; Rabin et al., 1993;
Aschner and Gannon, 1994) previously estimated carrier-mediated brain uptake of Mn
administered systemically as the ion. However, rapid respeciation of 54Mn in blood (or
in perfusates with anion ligands) confounded the identity of the transported Mn species.
For instance, using 54Mn2+ infused into (Murphy et al., 1991; Wadhwani et al., 1992),
injected into (Aschner and Gannon, 1994) or perfused with (Rabin et al., 1993) blood
allows the 54Mn2+ to associate with plasma albumin or cells, thus reducing the
concentration of free Mn available to cross into the brain. Similarly, Mn2+ can be
oxidized in blood or can associate with the small molecular weight ligands in plasma, as
modeled by Harris and Chen (1994). Furthermore, administration of Mn in buffered
solutions allows the formation of Mn complexes with HCO3-, SO42-, and H2PO4- with
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respective log stability constants of 0.45, 0.7 and 3.2 for their 1:1 complex formation
(NIST, 1995). The present study excluded all anions except chloride; chloride and
citrate; or chloride, transferrin and bicarbonate; in the uptake studies of 54Mn2+; 54Mn
citrate; and 54Mn Tf, respectively.

The results of the present work agree with earlier reports suggesting a role of carriermediated transport of Mn at the BBB (Murphy et al., 1991; Rabin et al., 1993).
54

54

Mn2+,

Mn citrate and 54Mn Tf entered the brain more rapidly than predicted by diffusion.

Choroid plexus Kin values were ten-fold greater than brain Kin values. This agrees with
earlier suggestions that the choroid plexus rapidly sequesters metals (Zheng et al.,
1991; Zheng, 2001). When we compare the parietal cortex 54Mn2+ uptake rate reported
herein with that previously reported in other perfusates, the Kin in the present work is
twice the value reported for 54Mn in whole blood and two-thirds the value reported for
buffered saline (Rabin et al., 1993). All three Kin values determined using the in situ
perfusion method are less than those reported for the cerebral cortex with the infusion
model (Murphy et al., 1991; Rabin et al., 1993). This may be due to rapid respeciation
of Mn, as discussed below.

Only in one brain region (pons/medulla) did the influx of 54Mn Tf exceed its predicted
rate of brain entry by diffusion. However, we did not conclude that Mn Tf enters the
brain via diffusion. It is widely accepted that Mn Tf can enter the brain via transferrin
receptor-mediated endocytosis (Aschner and Gannon, 1994; Aschner et al., 1999). The
lack of significantly greater Mn Tf uptake than predicted for a diffusion-mediated
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process into eight brain regions (shown in Table 2) may reflect two practical limitations
of these experiments. 1) The linear relationship for permeability described by Levin
may not apply to molecules as large as Mn Tf.

2) Endocytosis is a relatively slow

process compared to movement via ion channels and nutrient carriers. The higher
fraction (25%) of 54Mn Tf associated with the endothelial cells than seen with Mn2+ and
Mn citrate may reflect the slow rate of transferrin-receptor mediated endocytosis (2.5
molecules/ min/ receptor; (Cole and Glass, 1983; Bradbury, 1997). The brain regions
found to have higher Mn Tf influx rates generally have moderate to high Tf receptor
density (Hill et al., 1985). The Tf-dependent route of Mn brain entry appears to play a
limited role in total Mn uptake (Takeda et al., 2000; Malecki, 2001). Because these
results are in agreement with a commonly accepted mechanism, we did not further
study Mn Tf.

This is the first report of Mn citrate transfer coefficients at the BBB. The Mn citrate Kin
values are greater than predicted for Mn citrate diffusion and demonstrate clearly that
transport of Mn citrate at the BBB is being facilitated by some mechanism.
Furthermore, the Kin values for Mn citrate (3-51 x 10-5 ml/s/g) are generally higher than
those for Mn2+ determined in previous and the present (5-13 x 10-5 ml/s/g) experiments
(Murphy et al., 1991; Rabin et al., 1993). The infusion experiments of Murphy et al.
found faster Mn2+ influx in blood (32 x 10-5 ml/s/g at 80 nM) than Rabin et al. reported in
saline or blood with the in situ brain perfusion technique (~20 and ~8 x 10-5 ml/s/g).
From initial infusion to initial sampling, the 54Mn2+ had sufficient time (20 minutes) to
enter blood cells or bind to plasma proteins or small molecular weight ligands, including
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citrate, as described in the companion report (Yokel et al, submitted). Murphy et al.
measured the total uptake of all 54Mn species and found it to be greater than the uptake
of 54Mn2+ as administered by Rabin et al. This and the present work suggest that Mn
bound to small molecular weight ligands in plasma can enter the brain more rapidly than
the hydrated Mn ion. By excluding the small molecular weight ligands, we could
examine and differentiate the influx rates of hydrated Mn ion from Mn citrate. Even with
the considerable variability of the Mn citrate data and the correction for multiple
comparisons, we detected two regions with faster uptake of Mn citrate than Mn2+.
These different rates may be due to different affinities for the same carrier system(s) or
they may result from different carriers mediating Mn2+ and Mn citrate brain uptake.

Study V also suggests differences in Mn2+ and Mn citrate uptake systems.

Mn2+ can
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inhibit the influx of 54Mn2+, though the results did not show a concentration-dependent
inhibition across the 106-fold concentration range studied. In four brain regions the
influx was not inhibited by any tested concentration of 55Mn2+. The highest tested
concentration (107 nM) exceeds normal serum Mn concentrations by 500,000 fold
(Keen et al., 2000). Similar studies of Mn citrate showed inhibition in 3 of 9 brain
regions tested, with significant inhibition at the highest concentration of Mn citrate (107
nM). We did not extend the study beyond these 55Mn concentrations because 108 nM
Mn would significantly affect the osmolarity of the perfusate. These results agree with
Murphy’s description of a non-saturable component of Mn2+ uptake from blood (Murphy
et al., 1991). All of the brain regions tested were fit best, for at least one Mn species, by
an equation with one Michaelis-Menten (facilitated transport) term and a non-saturable
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(diffusion) term. However, the Km values generated are at the upper end of the
concentrations tested, and must be regarded in a qualitative manner only. The caudate
region, which is a relevant brain region in the pathology of manganism, produced Km
values near or below the highest Mn concentration tested for both Mn species. While
the Km values were significantly different (data not shown) for Mn2+ and Mn citrate, the
magnitudes of these values (>106 nM) are so great that it becomes physiologically
irrelevant. In the caudate, the Vmax values of Mn citrate and Mn2+ were significantly
different. This is evidence that, in at least one brain region, Mn2+ and Mn citrate have
different influx carriers or different affinities for the same carrier.

That Mn citrate plays an important role in brain influx becomes more apparent when we
observe Mn speciation in blood and relative influx rates. Thermodynamic modeling
suggests that 40% of the Mn available to cross the BBB is in the form of the hydrated
ion, while about 15% is Mn citrate. With about one-third the concentration and with an
uptake rate three times faster (40 vs. 13 x 10-5 ml/s/g in the parietal cortex), Mn citrate
total influx (J) equals or exceeds Mn ion influx. It appears that Mn citrate is a major
species of Mn that enters the brain.

Based on current knowledge of transporter systems at the BBB, we can make some
predictions about the potential carrier(s) for Mn2+ and Mn citrate. The most likely
candidates for mediating transport of the Mn ion (Mn2+) across mammalian membranes
are the divalent cation (metal) transporter (DCT1; DMT1; natural-resistance-associated
macrophage protein, Nramp2; Transporter family gene name: SLC11A2) and one or
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more members of the ABC superfamily. DCT1 serves as a high affinity non-transferrinbound iron membrane transporter (Garrick et al., 1999) with non-selective affinities for
Mn2+, Co2+, Fe2+, Ni2+, Cu2+, Zn2+ and Cd2+ (Knopfel et al., 2000; Picard et al., 2000). At
the dilute Mn and citrate concentrations and pH (7.4) of the perfusate studies herein,
they would be expected to form a 1:1 Mn citrate complex (Amico and Daniele, 1979).
Each citrate ion forms a tridentate complex with Mn involving the hydroxyl group and
two terminal carboxylates, leaving a non-coordinated central carboxylate (Glusker and
Carrell, 1973) which may serve as the recognition moiety of Mn citrate for an organic
anion transporter or a monocarboxylate transporter (MCT). Candidates for transport of
Mn citrate across mammalian membranes are harder to predict, but may include MCT
and/or members of the organic anion transporter polypeptide (Oatp) or ATP-binding
cassette (ABC) superfamilies.

In summary, 54Mn2+, 54Mn citrate and 54Mn Tf cross the BBB more quickly than can be
explained by diffusion, and 54Mn citrate enters more rapidly than 54Mn2+.
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Mn citrate

influx is inhibited by the addition of non-radioactive 55Mn citrate, and 55Mn2+ inhibits
influx of 54Mn2+. These results suggest influx across the BBB mediated by one or more
carriers. These results can be used to help identify the carrier(s) involved in Mn uptake
at the BBB and the mechanisms for regulation of brain Mn levels.
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Table 1: Octanol-Aqueous Partitioning Coefficients
(Do/a) and Predicted Brain Capillary Diffusion Rates
(Pdiffusion*S) for the Mn Species of this Report and
Two Diffusion Markers
Mn Species or
Diffusion Marker
Mn2+

3.6 x 10-6

Pdiffusion*S
shown × 105
(ml/s/g)
1.5 ± 0.1

Mn citrate

1.0 x 10-5

1.7 ± 0.2

8.0 x 10-4
(Pdiffusion directly
determined)

2.8 ± 0.5

Mn Tf
Sucrose1

Do/a

2.9

Dextran2
2.1 x 10-3
4.8
Manganese values shown are mean ± SEM for n=5-6.
1
Pdiffusion determined by (Levin, 1980). 2Do/a
determined by (Huang, 1990).
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Table 2: Influx Transfer Coefficients (Kin) for Three Mn Species in Rat Brain
Kin shown x 105 ml/s/g
BRAIN REGION
Frontal Cortex
Parietal Cortex

54

Mn2+
11 ± 4.0
54

13.1 ± 4.1*

Mn citrate

54

Mn Tf

41.8 ± 12.5*

6.0 ± 4.3‡

39.6 ± 13.0*

12.4 ± 5.6

Occipital Cortex
10.9 ± 5.7
51.1 ± 14.7*†
7.9 ± 4.8‡
Cerebellum
6.7 ± 2.3
22.5 ± 5.4*
1.9 ± 2.5‡
Caudate
4.7 ± 2.3
18.9 ± 4.8*
1.8 ± 2.0‡
Hippocampus
9.8 ± 3.1*
8.0 ± 8.9
2.7 ± 2.5
Thalamus/
hypothalamus
7.4 ± 3.1
31.1 ± 8.6*†
3.8 ± 3.7‡
Midbrain/
colliculus
8.8 ± 4.7
2.7 ± 17.1
13.2 ± 4.5*
Pons/ medulla
4.9 ± 2.0
9.9 ± 10.2
1.7 ± 3.7
Choroid Plexus
850 ± 468
463 ± 283
1383 ± 912
Values shown are mean ± SEM. Significant differences at the p<0.05 level are
noted as: * for Kin vs. diffusion (shown in Table 1), † for Mn citrate vs. Mn2+, and ‡ for
Mn citrate vs. Mn Tf.
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Table 3: Vascular Space of the Brain as Measured by [14C]-Sucrose
Delivered at Different Flow Rates
Vascular Space
µl/g brain
at 20 ml/min

at 10 ml/min

Frontal Cortex

10.5 ± 0.9

9.2 ± 0.9

Parietal Cortex

12.8 ± 1.5

10.7 ± 1.1

Occipital Cortex

13.2 ± 1.4

10.8 ± 0.9

Cerebellum

13.2 ± 1.6

12.3 ± 0.8

Caudate

6.8 ± 0.5

5.5 ± 0.4

Hippocampus

9.7 ± 1.0

8.4 ± 0.8

Thalamus/ hypothalamus
Midbrain/ colliculus

10.3 ± 1.0
11.0 ± 1.6

8.0 ± 0.8
9.0 ± 0.8

BRAIN REGION

Pons/ medulla
15.2 ± 1.5
13.5 ± 1.0
Choroid Plexus
235.8 ± 69.2
206.4 ± 37.6
Values shown are mean ± SEM for sixteen animals per flow rate after
perfusion for 90 seconds. There are no significant differences in vascular
space or in 54Mn2+ uptake rates (values not shown) when comparing these flow
rates for each brain region.
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Figure 1: Determination of Kin for Three Mn Species into
Rat Brain
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Figure 2: Effect of 55Mn species on 54Mn uptake
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Figure Legends

Figure 1: Determination of Kin for Three Mn Species into Rat Brain
Values shown are mean (± SEM) uptake space for the parietal cortex (♦) and predicted
uptake space for diffusion-only influx (•) for
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Mn2+ (1A),

54

Mn citrate (1B) and

54

Mn Tf

(1C). Regression analysis of individual results (——) produced the slopes listed in Table
2. For comparison, predicted uptake spaces for diffusion-only influxes are shown (– – –
).

Figure 2: Effect of 55Mn species on 54Mn uptake
Values are mean transfer coefficients (Kin) ± SEM with n=3-5 for each concentration. At
7 nM total Mn, there is no added 55Mn. Significant differences from 7 nM Mn (zero added
55

Mn) are noted as * p< 0.05.
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